SCHEMBL3295185

SCHEMBL3295185

CCCCOc1c(CC)cccc1[SiH](O[SiH](c1cccc(CC)c1OCCCC)c1cccc(CC)c1OCCCC)c1cccc(CC)c1OCCCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HPGD P15428 1/20 0.36
ATM Q13315 1/20 0.36
LTA4H P09960 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NR5A1 Q13285 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CSNK1D P48730 1/20 0.33
PRKCD Q05655 1/20 0.33
PAK1 Q13153 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3303338 0.85 MAPT (0.40) TLR4MEN1KMT2ATDP1MAPT
SCHEMBL3296500 0.82 ALDH1A1 (0.41) MEN1KMT2AMAPTLTA4HNPSR1
SCHEMBL3294491 0.82 CYP1A2 (0.46) MAPTCYP1A2CYP2C9CYP2C19TSHR
SCHEMBL3294191 0.80 GABRA1 (0.38) MEN1KMT2AMAPTL3MBTL1HPGD
SCHEMBL3296752 0.78 ALDH1A1 (0.39) TLR4LTA4HCYP1A2CYP2C9CYP2C19
SCHEMBL8939437 0.75 IAPP (0.47) MEN1KMT2ATDP1MAPTATM
SCHEMBL3297921 0.74 CYP1A2 (0.45) MEN1KMT2AMAPTL3MBTL1HPGD
SCHEMBL3296107 0.74 L3MBTL1 (0.45) MEN1KMT2AMAPTL3MBTL1HPGD
SCHEMBL3298713 0.73 LMNA (0.40) TLR4TDP1MAPTL3MBTL1LTA4H
SCHEMBL3302642 0.73 GABRA1 (0.39) MAPTL3MBTL1HPGDATMTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 TLR4 3223/4885MEN1 615/4885KMT2A 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.